Volution of Pulmonary Artery Dimensions in Tetralogy of Fallot

Study acronym: SEPT-TOF
StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Tetralogy of Fallot is the most common cyanotic congenital heart disease. Management strategies vary between primary repair and staged approaches including palliative surgery. The development of pulmonary arteries is a key determinant in surgical decision-making. This multicenter retrospective observational study aims to evaluate the evolution of pulmonary artery dimensions using the Nakata index at key stages of patient management (birth, palliative surgery, and complete repair). The goal is to assess its predictive value in optimizing surgical strategy and improving outcomes in patients with Tetralogy of Fallot or pulmonary atresia with ventricular septal defect.
Trial Details
NCT Number NCT07864129
Lead Sponsor University Hospital, Strasbourg, France
Conditions
(from sponsor)
Tetralogy of Fallot (TOF), Congenital Heart Defects
Related terms Heart Defects, Congenital, Tetralogy of Fallot
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov